Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitonin mesotherapy versus methylprednisolone injection for lumbar spinal canal stenosis
IRCT20240914063037N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of TBRIA and methylprednisolone in lumbar spinal stenosis (LSS) (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Pain and Function. Started Oct 2024; status: completed.
02
Drugs
TBRIAmethylprednisolone
03
Conditions
lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on IRCT20240914063037N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240914063037N1.